Your browser doesn't support javascript.
loading
Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein.
Raviprakash, K; Kochel, T J; Ewing, D; Simmons, M; Phillips, I; Hayes, C G; Porter, K R.
Afiliação
  • Raviprakash K; Virology Program, Infectious Diseases Department, Naval Medical Research Institute, 8901 Wisconsin Avenue, Bethesda, MD, USA. ravik@nmripo.nmri.nnmc.navy.mil
Vaccine ; 18(22): 2426-34, 2000 May 08.
Article em En | MEDLINE | ID: mdl-10738100
ABSTRACT
Recombinant plasmid DNA constructs expressing truncated or full-length dengue-1 envelope (E) with or without the pre-membrane (prM) were tested for immunogenicity in mice, as candidate dengue DNA vaccines. Two plasmids, one expressing the N-terminal 80% E and the other expressing prM and full length E were immunogenic in intradermally inoculated mice. The vaccinated mice produced dengue-1 specific antibodies that were both neutralizing and long lasting. Data suggested that the plasmid expressing prM and full length E produced virus like particles in transfected cells, and is probably a better immunogen compared to that expressing 80% E.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Vacinas Virais / Proteínas do Envelope Viral / Vacinas de DNA / Vírus da Dengue Idioma: En Ano de publicação: 2000 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Vacinas Virais / Proteínas do Envelope Viral / Vacinas de DNA / Vírus da Dengue Idioma: En Ano de publicação: 2000 Tipo de documento: Article